Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chayanit Mahasing"'
Autor:
Chayanit Mahasing, Pawinee Doungngern, Rittichai Jaipong, Poonyaporn Nonmuti, Jirapa Chimmanee, Jurai Wongsawat, Thananya Boonyasirinant, Chaisiri Wanlapakorn, Pattranee Leelapatana, Teerapat Yingchoncharoen, Tachapong Ngarmukos, Kulkanya Chokephaibulkit, Suphot Srimahachota
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1589 (2023)
The authors wish to make the following corrections to this published paper [...]
Externí odkaz:
https://doaj.org/article/6ac64bd49fbd482a981440d1aab0866c
Autor:
Chayanit Mahasing, Pawinee Doungngern, Rittichai Jaipong, Poonyaporn Nonmuti, Jirapa Chimmanee, Jurai Wongsawat, Thananya Boonyasirinant, Chaisiri Wanlapakorn, Pattranee Leelapatana, Teerapat Yingchoncharoen, Tachapong Ngarmukos, Kulkanya Chokephaibulkit, Suphot Srimahachota
Publikováno v:
Vaccines, Vol 11, Iss 4, p 749 (2023)
Background: Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency use. Adverse event following immunization (AEFI) surveillance has bee
Externí odkaz:
https://doaj.org/article/66940debbd864c59873c5fc21099ff87
Autor:
Chayanit Mahasing, Oiythip Yasopa, Chalo Sansilapin, Thanit Rattanathumsakul, Panithee Thammawijaya, Rapeepong Suphanchaimat, Pawinee Doung-ngern
Publikováno v:
Vaccines, Vol 10, Iss 3, p 441 (2022)
On 28 April 2021, the investigation team of the Department of Disease Control, Ministry of Public Health, was notified of a cluster of people developing neurological symptoms following COVID-19 vaccination in a province in eastern Thailand. We conduc
Externí odkaz:
https://doaj.org/article/b1d735b3b48a4fb49347a1b9a02f9db2
Autor:
Chayanit Mahasing, Wanitchaya Kittikraisak, Joshua A Mott, Pornsak Yoocharoen, Phunlerd Piyaraj, Chuleekorn Tanathitikorn, Somsak Punjasamanvong, Thanapat Wongrapee, Patama Suttha, Thanit Rattanathumsakul, William W Davis, Matthew Westercamp, Suthat Chottanapund
Publikováno v:
Annals of Work Exposures and Health.
Objectives Personal protective equipment (PPE) use is associated with reduced risk of SARS-CoV-2 infection among healthcare personnel (HCP). There are limited data on the impact of the novel coronavirus disease 2019 (COVID-19) pandemic on the PPE use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b454057ec1e2dd63df849b53e7e9335d
https://doi.org/10.1093/annweh/wxad015
https://doi.org/10.1093/annweh/wxad015